These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 26385421)

  • 61. Novel MLH1 duplication identified in Colombian families with Lynch syndrome.
    Alonso-Espinaco V; Giráldez MD; Trujillo C; van der Klift H; Muñoz J; Balaguer F; Ocaña T; Madrigal I; Jones AM; Echeverry MM; Velez A; Tomlinson I; Milà M; Wijnen J; Carvajal-Carmona L; Castells A; Castellví-Bel S
    Genet Med; 2011 Feb; 13(2):155-60. PubMed ID: 21233718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases.
    Diniz G; Aktas S; Cubuk C; Ortac R; Vergin C; Olgun N
    Pediatr Hematol Oncol; 2013 May; 30(4):273-84. PubMed ID: 23570624
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mismatch repair gene deficiency and genetic anticipation in Lynch syndrome: myth or reality?
    Ponti G; Ruini C; Tomasi A
    Dis Colon Rectum; 2015 Jan; 58(1):141-2. PubMed ID: 25489705
    [No Abstract]   [Full Text] [Related]  

  • 65. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.
    Aysal A; Karnezis A; Medhi I; Grenert JP; Zaloudek CJ; Rabban JT
    Am J Surg Pathol; 2012 Feb; 36(2):163-72. PubMed ID: 22189970
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
    Ponti G; Manfredini M; Tomasi A; Pellacani G
    Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
    Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
    N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Integrated analysis of unclassified variants in mismatch repair genes.
    Pastrello C; Pin E; Marroni F; Bedin C; Fornasarig M; Tibiletti MG; Oliani C; Ponz de Leon M; Urso ED; Della Puppa L; Agostini M; Viel A
    Genet Med; 2011 Feb; 13(2):115-24. PubMed ID: 21239990
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.
    Parry S; Win AK; Parry B; Macrae FA; Gurrin LC; Church JM; Baron JA; Giles GG; Leggett BA; Winship I; Lipton L; Young GP; Young JP; Lodge CJ; Southey MC; Newcomb PA; Le Marchand L; Haile RW; Lindor NM; Gallinger S; Hopper JL; Jenkins MA
    Gut; 2011 Jul; 60(7):950-7. PubMed ID: 21193451
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012.
    Rahner N; Steinke V; Schlegelberger B; Eisinger F; Hutter P; Olschwang S
    Eur J Hum Genet; 2013 Jan; 21(1):. PubMed ID: 22892529
    [No Abstract]   [Full Text] [Related]  

  • 71. Interobserver variability in the evaluation of mismatch repair protein immunostaining.
    Klarskov L; Ladelund S; Holck S; Roenlund K; Lindebjerg J; Elebro J; Halvarsson B; von Salomé J; Bernstein I; Nilbert M
    Hum Pathol; 2010 Oct; 41(10):1387-96. PubMed ID: 20573374
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
    J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome.
    Alvarez K; Hurtado C; Hevia MA; Wielandt AM; de la Fuente M; Church J; Carvallo P; López-Köstner F
    Dis Colon Rectum; 2010 Apr; 53(4):450-9. PubMed ID: 20305446
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays.
    Thompson BA; Martins A; Spurdle AB
    Clin Genet; 2015 Feb; 87(2):100-8. PubMed ID: 24989436
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndrome.
    Barrow E; Jagger E; Brierley J; Wallace A; Evans G; Hill J; McMahon R
    Histopathology; 2010 Feb; 56(3):331-44. PubMed ID: 20459533
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
    Jessup CJ; Redston M; Tilton E; Reimann JD
    Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.
    Lin KM; Shashidharan M; Thorson AG; Ternent CA; Blatchford GJ; Christensen MA; Watson P; Lemon SJ; Franklin B; Karr B; Lynch J; Lynch HT
    J Gastrointest Surg; 1998; 2(1):67-71. PubMed ID: 9841970
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.
    Win AK; Reece JC; Buchanan DD; Clendenning M; Young JP; Cleary SP; Kim H; Cotterchio M; Dowty JG; MacInnis RJ; Tucker KM; Winship IM; Macrae FA; Burnett T; Le Marchand L; Casey G; Haile RW; Newcomb PA; Thibodeau SN; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
    Fam Cancer; 2015 Dec; 14(4):575-83. PubMed ID: 26202870
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family.
    Cini G; Carnevali I; Quaia M; Chiaravalli AM; Sala P; Giacomini E; Maestro R; Tibiletti MG; Viel A
    Carcinogenesis; 2015 Apr; 36(4):452-8. PubMed ID: 25742745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.